Vapotherm Blog

Safe Patient Care with Vapotherm High Velocity Therapy

Whether on the general care floor, in the emergency room, or the ICU, Vapotherm devices are designed with patient safety in mind. There are inherent risks in using any medical device on sick patients. Here are the ways in which we strive to give you confidence that you’re providing your respiratory distress patient with safe

AARC Safe and Effective Staffing Guide Recognizes High Velocity Therapy as NIV

The AARC released their Safe and Effective Staffing Guide (previous known as the AARC Uniform Reporting Manual (URM)), the association’s official productivity guide with time standards for most Respiratory Care Department procedures. The time standards are based on 2020 survey results from hundreds of US Respiratory Care Department Directors and Managers. In the new guide,  high

New Analysis Shows that Preterm Babies Can Be Effectively Stabilized in Delivery Room Using Vapotherm® as Primary Respiratory Support

In February 2021, Siva and Reynolds published the results of a retrospective, single center, observational cohort study in Acta Paediatrica titled “Stabilisation of the preterm infant in the delivery room using nasal high flow: A 5—year retrospective analysis.” The analysis examined the clinical outcomes of premature neonates stabilized in the delivery room to determine the

Image of elderly male patient with a Vapotherm cannula smiling at a tablet he’s using. A Vapotherm Precision Flow is visible in the background.

New Study Adds Evidence for Use of Vapotherm® High Velocity Therapy as First-Line Support on Severely Hypercapnic COPD Patients

Vapotherm high velocity therapy is an attractive alternative to traditional noninvasive positive pressure ventilation (NiPPV) for respiratory distress. This approach — which is a form of Mask-Free NIV® — redefines the notion that ventilatory support requires a mask-and-pressure-based mechanism of action.

Image of a chest x-ray showing grayness in the lungs

Keeping This Complex COVID-19 Patient Off the Vent —A Case Story of Inhaled Epoprostenol, High Velocity Therapy, and Healthcare Team Perseverance

Although individual results may vary, Vapotherm believes this case story is an example of the clinical benefit Vapotherm’s high velocity therapy can have in an ICU setting. About six months into the COVID-19 pandemic, 61-year-old Ethan* was admitted to the ICU with complications from COVID-19 and comorbidities including stage III chronic kidney disease.

Image of Dr. Atwood

Velocity – Ep 9 – Physicians discuss research on Mask-Free NIV for COPD patients

In this episode, Dr. Kirk Hinkley interviews esteemed researcher and pulmonologist Dr. Charles Atwood about the latest research concerning use of high velocity therapy for COPD patients. They discuss an article by Doshi and colleagues published in March of 2020 in Heart & Lung. Dr. Atwood breaks down the research and offers his insight as to the clinical practice implications of the results.

Image of Nan Nathenson

BreatheTV Episode 25 – Importance of Early Mobilization | A Webinar with NAN Nathenson, RRT

Jeff Maglin: It’s now my pleasure to introduce our speaker Nan Nathenson. Nan is a respiratory therapist and educator. She has worked in nearly every level care including critical care and rehabilitation settings. In her experience, she has narrowed the gaps between levels of care.

Image of a hospital room with a patient in the distance and a vitals monitor in the front

How are Hospitals and Respiratory Care Departments Reimbursed for Respiratory Care Services?

For most products, paying for a service or item is a simple transaction based on the listed price. The merchant posts the price, the consumer agrees, makes the payment, and gets the product. As healthcare providers, we are bombarded with the question: ‘Why can’t you operate like other businesses?’

Image of clinicians gathered around what appears to be an operating table

What Authority/Influence Do Respiratory Care Leaders Have with Regard to Productivity Measures and Benchmarking?

In talking with Respiratory Therapy leaders about productivity for more than a few years, their responses about their authority range from ‘none’ to ‘done’. Those replying that they have no authority indicate that administration has chosen the metric to use for each department and there is no possibility of replacing this.

Image of a nurse examining a neonate in the NICU

What is Benchmarking and How are Performance Metrics Used for Benchmarking in the Context of RT Department Productivity?

In a previous blog, I went into detail about various metrics and how to assess the validity of metrics when examining Respiratory Department Productivity. Here I’m going to review commonly used metrics in our hospitals and define each, discuss the validity of each, and how to best capture and use these metrics so that you can effectively establish safe and effective staffing levels to ensure high quality.